Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Calavo Growers (CVGW) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Calavo Growers (CVGW) over the last 17 years, with Q4 2025 value amounting to $113.0 million.

  • Calavo Growers' Cost of Revenue fell 2644.39% to $113.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $584.8 million, marking a year-over-year decrease of 153.1%. This contributed to the annual value of $584.8 million for FY2025, which is 151.06% down from last year.
  • According to the latest figures from Q4 2025, Calavo Growers' Cost of Revenue is $113.0 million, which was down 2644.39% from $160.6 million recorded in Q3 2025.
  • Calavo Growers' Cost of Revenue's 5-year high stood at $323.5 million during Q3 2022, with a 5-year trough of -$179.1 million in Q4 2022.
  • Its 5-year average for Cost of Revenue is $171.1 million, with a median of $160.1 million in 2024.
  • Per our database at Business Quant, Calavo Growers' Cost of Revenue crashed by 16775.08% in 2022 and then skyrocketed by 17144.55% in 2023.
  • Over the past 5 years, Calavo Growers' Cost of Revenue (Quarter) stood at $264.3 million in 2021, then plummeted by 167.75% to -$179.1 million in 2022, then surged by 171.45% to $127.9 million in 2023, then increased by 20.11% to $153.7 million in 2024, then decreased by 26.44% to $113.0 million in 2025.
  • Its last three reported values are $113.0 million in Q4 2025, $160.6 million for Q3 2025, and $172.5 million during Q2 2025.